AbbVie (ABBV) Work In Process (2012 - 2016)

AbbVie has disclosed Work In Process across 5 years of filings, most recently posting $1.1 billion for Q2 2016.

• In Q2 2016, Work In Process rose 4.81% year-over-year to $1.1 billion; the TTM figure through Jun 2016 stood at $1.1 billion (up 4.81% YoY), while the FY2015 annual figure was $1.1 billion, up 71.86% from the prior year.
• Work In Process fell to $1.1 billion in Q2 2016, from $1.1 billion in the prior quarter.
• Over the last five years, Work In Process for ABBV reached as high as $1.1 billion in Q1 2016 and fell as low as $262.0 million in Q1 2013.
• The 5-year median for Work In Process is $568.0 million (2015), against an average of $672.0 million.
• Annual changes were most pronounced in 2015 — Work In Process surged 122.85% — and 2016, when it gained 4.81%.
• A 5-year view of Work In Process shows it stood at $286.0 million in 2012, then jumped by 41.26% to $404.0 million in 2013, then jumped by 55.69% to $629.0 million in 2014, then jumped by 71.86% to $1.1 billion in 2015, then slipped by 1.2% to $1.1 billion in 2016.
• According to Business Quant data, Work In Process over the past three periods registered $1.1 billion, $1.1 billion, and $1.1 billion for Q2 2016, Q1 2016, and Q4 2015 respectively.